Aspira Women’s Health (NYSE:AWH) Research Coverage Started at StockNews.com

Investment analysts at StockNews.com began coverage on shares of Aspira Women’s Health (NYSE:AWH – Get Rating) in a report released on Sunday. The brokerage set a “sell” rating on the stock.

Aspira Women’s Health Stock Performance

Shares of NYSE:AWH opened at $0.40 on Friday. Aspira Women’s Health has a 1 year low of $0.29 and a 1 year high of $1.26. The stock has a market cap of $49.84 million, a P/E ratio of -1.48 and a beta of 2.96. The firm’s 50-day simple moving average is $0.47.

About Aspira Women’s Health

(Get Rating)

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.